Plasma LTE4/PGF2α Ratio and Blood Eosinophil Count Are Increased in Elderly Asthmatics With Previous Asthma Exacerbation

다국어 초록 (Multilingual Abstract)

The tools for asthma control assessment recommended by the current guideline are cognitive function- and effort-dependent, which is substantially impaired in the elderly. The aim of this study is to investigate objective assessment tools of asthma control status and previous asthma exacerbation (AE) in elderly subjects. Asthmatics aged >60 years who were treated with step 2 or 3 by the Global Initiative for Asthma (GINA) guideline were enrolled. During the 12-week study period, the subjects used either 400 μg of budesonide plus 10 mg of montelukast or 800 μg of inhaled budesonide. The occurrence of AE during the 4-week run-in and 12-week treatment period was monitored. After 12-week of treatment, sputum eosinophil count, peripheral eosinophil count, the plasma leukotriene E4 (LTE4), and prostaglandin F2α (PGF2α) metabolite levels were measured using the UHPLC/Q-ToF MS system. The study subjects were divided into group 1 (asthmatics who experienced AE during the study period) and group 2 (those who did not). A total of 101 patients aged 60-85 years were enrolled. Twenty-three patients (22.8%) had experienced AE. The plasma LTE4 level, LTE4/PGF2α ratio, and peripheral eosinophil count were significantly higher in group 1 than in group 2 (P=0.023, P=0.010, P=0.033, respectively).
The plasma LTE4/PGF2α ratio and peripheral eosinophil count at week 12 were significantly associated with previous AE (odds ratio [OR]=1.748, P=0.013; OR=1.256, P=0.027). Receiver operating characteristic (ROC) curves to discriminate the subjects with previous AE, including these 2 parameters, showed that the area under the curve was 0.700 (P=0.004), with 73.9% sensitivity and 47.9% specificity. In conclusion, a combination of plasma LTE4/PGF2α ratio and peripheral eosinophil count can be an objective assessment tool which is significantly associated with asthma control status in elderly asthmatics.

참고문헌 (Reference)

1 Puranik S, "Predicting severe asthma exacerbations in children" 2016

2 Sampson AP, "Persistent increase in plasma and urinary leukotrienes after acute asthma" 73 : 221-225, 1995

3 송우정, "More Effective Strategies are Needed for Elderly Asthmatics in Real-World Practice" 대한천식알레르기학회 7 (7): 419-420, 2015

4 Ban GY, "Metabolomic analysis identifies potential diagnostic biomarkers for aspirin‐exacerbated respiratory disease" 47 : 37-47, 2017

5 Green SA, "Increase in urinary leukotriene LTE4 levels in acute asthma: correlation with airflow limitation" 59 : 100-104, 2004

6 Global Initiative for Asthma, "Global strategy for asthma management and prevention: 2016 (revision)" Global Initiative for Asthma

7 Mondino C, "Effects of inhaled corticosteroids on exhaled leukotrienes and prostanoids in asthmatic children" 114 : 761-767, 2004

8 박진경, "Diseases Concomitant With Asthma in Middle-Aged and Elderly Subjects in Korea: A Population-Based Study" 대한천식알레르기학회 5 (5): 16-25, 2013

9 Kanaoka Y, "Cysteinyl leukotrienes and their receptors;emerging concepts" 6 : 288-295, 2014

10 Baraldi E, "Cysteinyl leukotrienes and 8-isoprostane in exhaled breath condensate of children with asthma exacerbations" 58 : 505-509, 2003

11 송우정, "Challenges in the Management of Asthma in the Elderly" 대한천식알레르기학회 7 (7): 431-439, 2015

12 Yáñez A, "Asthma in the elderly: what we know and what we have yet to know" 7 : 8-25, 2014

13 Hanania NA, "Asthma in the elderly: current understanding and future research needs--a report of a National Institute on Aging (NIA) workshop" 128 : S4-S24, 2011

14 예영민, "Addition of Montelukast to Low-Dose Inhaled Corticosteroid Leads to Fewer Exacerbations in Older Patients Than Medium- Dose Inhaled Corticosteroid Monotherapy" 대한천식알레르기학회 7 (7): 440-448, 2015